Navigation Links
Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows
Date:11/25/2008

Results reveal most respondents against expanding statin use broadly in wake of AHA-presented data

LITTLE FALLS, N.J., Nov. 25 /PRNewswire/ -- JUPITER, a clinical trial suggesting rosuvastatin may lower the cardiovascular risk of healthy patients with elevated CRP, should not prompt universal statin use in older adults, according to a national poll directed at health professionals. Some 1,212 participants took part in the online poll conducted by medical news site MedPage Today LLC (www.MedPageToday.com).

(Photo: http://www.newscom.com/cgi-bin/prnh/20081125/NY48420 )

While the news coming out of the American Heart Association (AHA) Scientific Sessions on JUPITER was dramatic, respondents voted 60% to 40% against automatically prescribing statins in patients 60+ without elevated cholesterol.

"Our poll shows that healthcare professionals may not be so quick to change their Crestor or statin prescribing habits based on the results presented at AHA," said Robert Stern, President and CEO of MedPage Today. "The JUPITER results have created a debate between clinical data and the implications for real-world medical practice."

Whether the indication for Crestor should be expanded dramatically to include healthy patients became a major question after the JUPITER findings were presented at AHA and then published online in the New England Journal of Medicine.

In the clinical trial, 20 mg of rosuvastatin (Crestor) taken daily for just under two years reduced median LDL cholesterol to 55 mg/dL, down from a median of 108 mg/dL, and median hs-CRP (high-sensitivity C-reactive protein), a test measuring inflammation, by 37%. The corresponding reduction in the rate of heart attack, stroke, bypass su
'/>"/>

SOURCE MedPage Today, LLC
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
2. Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged
3. New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
4. NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs
5. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
6. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
7. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
8. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
9. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
10. Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress
11. Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Mass. , May 21, 2013 /PRNewswire/ ... research and advisory firms for pharmaceutical and ... an emerging agent on key efficacy endpoints, ... progression, has the most influence over surveyed ... advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast cancer. ...
(Date:5/21/2013)... , May 21, 2013 iHealth ... manufacture of wireless personal healthcare products and a ... reach, announcing the release of two new fitness ... pressure monitors and scales: the Wireless Pulse Oximeter ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth ...
(Date:5/21/2013)... Md. , May 21, 2013 ... disposable drug-free consumer electronic devices, announced that CEO, ... presenting today to the FDA,s Medical Advisory Committee, ... the company,s products for over the counter sales. ... FDA developed its medical device classification schema," Whelan ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... Calif. and FORT WASHINGTON, Pa., Oct. 19, 2011 ... and fitness measurement utilizing biometric testing devices and ... in consumer focused, health engagement digital messaging, today ... solutions in the retail and non-retail markets. ...
... ATLANTA, Oct. 19, 2011 VaxyGen ... of an exclusive license and collaboration agreement with ... VaxyGen the exclusive license to a novel patent ... biopharmaceutical and vaccine products. In addition, VaxyGen and ...
Cached Medicine Technology:ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 2ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 3ADFLOW Health Networks and Stayhealthy Form Strategic Partnership to Deploy the Most Comprehensive Biometric Screening and Consumer Health Engagement Platform in U.S. 4VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How 2VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How 3
(Date:5/21/2013)... (PRWEB) May 21, 2013 Phoseon Technology ... at the 20th Annual IMI European Ink Jet ... proven market leader, Phoseon continues to invest in product ... the adoption of UV LED curing in printing applications. ... families on the market offering both air cooled and ...
(Date:5/21/2013)... Global Proving Ground (GPG), a fast rising ... retailer of health and fitness supplements, are partnering up ... Island. “We cast the show by having millions ... our unique social networking platform,” states show’s creator James ... an island in the Pacific Ocean, where they must ...
(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 ... With the help of Texas Counseling’s Sexuality and ... communication, and the development of healthier habits for ... workshops available for both couples and individuals at ... enhance their relationships and learn skills to develop ...
(Date:5/21/2013)... the roles two proteins, thrombospondin-1 and prosaposin, play ... has identified a five-amino acid fragment of prosaposin ... of prostate, breast and lung cancer. The findings ... metastasis in a variety of cancers. , ... at Boston Children,s Hospital, Vivek Mittal, PhD, at ...
(Date:5/21/2013)... University of Cincinnati (UC) researchers have identified a number ... help with earlier diagnosis and intervention in those who ... first of its kind and led by UC,s Bruce ... staff from Walter Reed National Military Medical Center at ... Orlando, Fla. , The DoDSR is a biological ...
Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Biomarkers discovered for inflammatory bowel disease 2
... , , BOULDER, Colo., July 30 ... owning patented surgical technology that is emerging as a standard of ... quarter of fiscal year 2010. , , Net ... representing a 3% increase over net sales of $3.1 million for ...
... , SAO PAULO, July 30 Frost & Sullivan ... recipient of the 2009 Market Penetration Leadership Award ... offers a complete portfolio of solutions including digital and computed radiography, ... by the needs of customers willing to enter in the digital ...
... , , CHICAGO, July ... the world,s largest scientific/medical society dedicated to advancing research and ... of the human lifespan, unveils an innovative, technology-based fix to ... Increase the lifespan, or improve the healthspan, of all ...
... ... America, will award prizes to young filmmakers, 25 years of age and under, ... America. The top three winners will receive cash prizes of $5,000, $3,500 and ... 5-12 minutes creative films online, where the public will partake in the first ...
... ... provide students with an excellent option for a less expensive education in the thriving ... ... the nursing shortage creates opportunity for the qualified nurse, and online nursing degrees are ...
... DALLAS July 30, 2009 The typical dose ... is much too low to account for modern-day physiques, ... The finding, reported online and in the August edition ... important for those living in societies plagued by obesity, ...
Cached Medicine News:Health News:Encision Reports Profitable First Fiscal Quarter Results 2Health News:Encision Reports Profitable First Fiscal Quarter Results 3Health News:Encision Reports Profitable First Fiscal Quarter Results 4Health News:Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009 2Health News:Frost & Sullivan Awards Agfa Healthcare for Brazilian Market Penetration Leadership in 2009 3Health News:Obama White House Can Save $3.7 Trillion and Extend Lifespan 29+ Years, Predicts Revolutionary A4M Healthcare Plan 2Health News:Call to the Youth of America: Palms for Life Fund Launches Film Competition to Document Hunger in the United States 2Health News:All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 3
... Mumps IgM Enzyme-Linked Immunosorbent Assay ... qualitative detection of IgM antibody ... for the determination of immunological ... this kit have not been ...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in...
... announced the launch of the Chilli ... bi-directional cooled-tip catheter available in the United ... physicians the benefits of cooled ablation technology ... Boston Scientific Blazer(R) catheter platform. ,Cooled cardiac ...
... wire crosses the lesion first, independent of ... actions, including filter placement and retrieval, balloon ... the wire., ,Emboshield is designed to capture ... carotid stenting procedure, and it is the ...
Medicine Products: